New York Life Investment Management LLC
Position in KRYS — Krystal Biotech, Inc.
CIK 1133639
New York, NY
Position in KRYS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,177,078
+$641,884 QoQ
Shares Held
3,167
-26.6% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#188
of 419 holders
Holding Since
Mar 2023
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KRYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026New York Life Investment Management LLC holds $63,828,425 across 23 Biotechnology names. KRYS ranks #13 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
43,218 | $21,467,677 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
16,588 | $10,343,281 | |
| 3 | MRNA |
Moderna, Inc.
|
91,235 | $6,389,187 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
23,449 | $4,391,528 | |
| 5 | TECH |
BIO-TECHNE Corp
|
41,589 | $2,938,262 | |
| 6 | INCY |
Incyte Corp
|
23,359 | $2,647,976 | |
| 7 | EXEL |
Exelixis, Inc.
|
29,245 | $1,591,220 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
24,104 | $1,379,230 |
All Filings in KRYS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,177,078 | 3,167 | Shares | Sole | 2026-08-10 | |
| 2023-12-31 | $535,194 | 4,314 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $515,040 | 4,440 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $604,375 | 5,148 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $472,754 | 5,905 | Shares | Sole | 2023-05-08 | |
| No filing history on record for this holder in this stock. | ||||||